State-based agenda seeks to maximise US medtech growth
This article was originally published in Clinica
Executive Summary
The US’ global leadership in the development of medical technology is eroding, acknowledges AdvaMed president and CEO Stephen Ubl, but he says that there are steps that the states can take to attract more companies and maintain competitive industries locally.